Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(16 sites)
United States
Mayo Clinic in Arizona, Scottsdale, Arizona Mayo Clinic in Florida, Jacksonville, Florida Cleveland Clinic Weston Florida, Weston, Florida University of Chicago Comprehensive Cancer Center, Chicago, Illinois Carle Cancer Center NCI Community Oncology Research Program, Urbana, Illinois University Medical Center New Orleans, New Orleans, Louisiana Michigan Cancer Research Consortium NCORP, Ann Arbor, Michigan University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan Mayo Clinic in Rochester, Rochester, Minnesota Roswell Park Cancer Institute, Buffalo, New York Duke University Medical Center, Durham, North Carolina University Hospitals Cleveland Medical Center, Cleveland, Ohio Allegheny General Hospital, Pittsburgh, Pennsylvania Rapid City Regional Hospital, Rapid City, South Dakota Froedtert and the Medical College of Wisconsin LAPS, Milwaukee, Wisconsin Medical College of Wisconsin, Milwaukee, Wisconsin Age range
18 Years and older
Last updated September 2025